Information Provided By: 
Fly News Breaks for September 24, 2018
AYX
Sep 24, 2018 | 08:46 EDT
Needham analyst Jack Andrews raised his price target on Alteryx to $65 and kept his Buy rating after last week's presentation by the company's "Lead Technology Evangelist Nick Jewell" on its latest release of Alteryx Analytics. The analyst cites the platform's "new visualytics feature" bringing together interactive charting, support for the "heavily requested" Python language and its "leading library of machine learning algorithms". Andrews contends that Alteryx's self-service tools "enable a pivotal function in the Big Data software stack".
News For AYX From the Last 2 Days
AYX
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
